Metadata
- Name
- Phase 1 Trial of CXD101 in Patients With Advanced Cancer
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT01977638
- Description
- The purpose of this study is to determine the highest dose of CXD101 (a novel histone
deacetylase inhibitor) that can be safely administered to patients with advanced tumours. The
study will also investigate the use of HR23B expression in tumour as a biomarker of response
to treatment with CXD101. Patients with solid tumours, lymphoma and myeloma can be considered
for this study. - Data or Study Types
- clinical trial
- Keywords
- Advanced solid tumours, Lymphoma, Myeloma
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2013
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT01977638
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT01977638